1.Alpha-Tocopherol-Loaded Liposomes Reduce High Glucose Induced Oxidative Stress in Schwann Cells: A Proof of Concept Study
Jee-In HEO ; Mi Jeong KIM ; Daehyun KIM ; Jimin SEO ; Joon Ho MOON ; Sung Hee CHOI ; Hak Jong LEE ; Tae Jung OH
Diabetes & Metabolism Journal 2025;49(3):507-512
Although oxidative stress is the main pathophysiology of the development of diabetic neuropathy, oral administration of antioxidants has given disappointing results. Here, we hypothesized that local delivery of antioxidants would provide protective effects on Schwann cells due to the high concentration of local lesions. We prepared alpha-tocopherol (ATF)-loaded liposomes and tested their skin penetration after sonication. An in vitro study using IMS-32 cells was conducted to determine the level of reactive oxygen species (ROS) scavenging effects of ATF-liposomes. ATF reduced ROS in high-glucose-exposed IMS-32 cells in a dosedependent manner. ATF-liposomes also reduced the ROS level in vitro and ultrasound irradiation enhanced delivery to the dermis in porcine ear skin. This study showed that it is feasible to deliver ATF through the skin and can effectively reduce ROS. This model is worthy of development for clinical use.
2.Alpha-Tocopherol-Loaded Liposomes Reduce High Glucose Induced Oxidative Stress in Schwann Cells: A Proof of Concept Study
Jee-In HEO ; Mi Jeong KIM ; Daehyun KIM ; Jimin SEO ; Joon Ho MOON ; Sung Hee CHOI ; Hak Jong LEE ; Tae Jung OH
Diabetes & Metabolism Journal 2025;49(3):507-512
Although oxidative stress is the main pathophysiology of the development of diabetic neuropathy, oral administration of antioxidants has given disappointing results. Here, we hypothesized that local delivery of antioxidants would provide protective effects on Schwann cells due to the high concentration of local lesions. We prepared alpha-tocopherol (ATF)-loaded liposomes and tested their skin penetration after sonication. An in vitro study using IMS-32 cells was conducted to determine the level of reactive oxygen species (ROS) scavenging effects of ATF-liposomes. ATF reduced ROS in high-glucose-exposed IMS-32 cells in a dosedependent manner. ATF-liposomes also reduced the ROS level in vitro and ultrasound irradiation enhanced delivery to the dermis in porcine ear skin. This study showed that it is feasible to deliver ATF through the skin and can effectively reduce ROS. This model is worthy of development for clinical use.
3.Alpha-Tocopherol-Loaded Liposomes Reduce High Glucose Induced Oxidative Stress in Schwann Cells: A Proof of Concept Study
Jee-In HEO ; Mi Jeong KIM ; Daehyun KIM ; Jimin SEO ; Joon Ho MOON ; Sung Hee CHOI ; Hak Jong LEE ; Tae Jung OH
Diabetes & Metabolism Journal 2025;49(3):507-512
Although oxidative stress is the main pathophysiology of the development of diabetic neuropathy, oral administration of antioxidants has given disappointing results. Here, we hypothesized that local delivery of antioxidants would provide protective effects on Schwann cells due to the high concentration of local lesions. We prepared alpha-tocopherol (ATF)-loaded liposomes and tested their skin penetration after sonication. An in vitro study using IMS-32 cells was conducted to determine the level of reactive oxygen species (ROS) scavenging effects of ATF-liposomes. ATF reduced ROS in high-glucose-exposed IMS-32 cells in a dosedependent manner. ATF-liposomes also reduced the ROS level in vitro and ultrasound irradiation enhanced delivery to the dermis in porcine ear skin. This study showed that it is feasible to deliver ATF through the skin and can effectively reduce ROS. This model is worthy of development for clinical use.
4.Alpha-Tocopherol-Loaded Liposomes Reduce High Glucose Induced Oxidative Stress in Schwann Cells: A Proof of Concept Study
Jee-In HEO ; Mi Jeong KIM ; Daehyun KIM ; Jimin SEO ; Joon Ho MOON ; Sung Hee CHOI ; Hak Jong LEE ; Tae Jung OH
Diabetes & Metabolism Journal 2025;49(3):507-512
Although oxidative stress is the main pathophysiology of the development of diabetic neuropathy, oral administration of antioxidants has given disappointing results. Here, we hypothesized that local delivery of antioxidants would provide protective effects on Schwann cells due to the high concentration of local lesions. We prepared alpha-tocopherol (ATF)-loaded liposomes and tested their skin penetration after sonication. An in vitro study using IMS-32 cells was conducted to determine the level of reactive oxygen species (ROS) scavenging effects of ATF-liposomes. ATF reduced ROS in high-glucose-exposed IMS-32 cells in a dosedependent manner. ATF-liposomes also reduced the ROS level in vitro and ultrasound irradiation enhanced delivery to the dermis in porcine ear skin. This study showed that it is feasible to deliver ATF through the skin and can effectively reduce ROS. This model is worthy of development for clinical use.
5.Development of evaluation items for accessing practice and compliance with dietary guidelines among Korean adults
Min-Ah KIM ; Sung-Min YOOK ; Jieun OH ; Jimin LIM ; Hye Ji SEO ; Young-Suk LIM ; Ji Soo OH ; Hye-Young KIM ; Ji-Yun HWANG
Journal of Nutrition and Health 2024;57(2):244-260
Purpose:
With the 2021 revision of dietary guidelines in Korean emphasizing environmentally sustainable dietary practices, this study attempted to develop an evaluation tool to comprehensively evaluate the degree of practice and compliance with food and nutrient intake, dietary habits, and dietary culture guidelines based on the revised dietary guidelines.
Methods:
The candidate evaluation items were collected by reviewing 934 literature reviews on domestic and foreign dietary evaluations. Fifty-nine candidate items were derived by selecting the items corresponding to dietary guidelines. The content validity ratio (CVR) cutoff point evaluation was conducted with 11 experts to delete 11 items that did not meet the CVR standard. Fifty-five pilot survey candidate items were selected through revision and additional process according to expert opinion. Seventy final candidate items were selected by adding 15 questions for validity verification and reference. A pilot survey was conducted online and offline on 332 adults aged 19–64 in Seoul and the metropolitan area, and exploratory factor analysis was used to verify the construct validity of the evaluation items. Through exploratory factor analysis, the Kaiser–Meyer–Olkin, Bartlett's sphericity test, variance explained, and Cronbach's alpha criteria were confirmed in each process.
Results:
Exploratory factor analyses derived three criteria: food and nutrient intakes (11 items), eating behaviors (9 items), and dietary culture (14 items), consisting of 34 evaluation items.
Conclusion
The present scale was validated and can be used for comprehensive evaluations of the dietary guidelines for Korean adults in a simple way.
6.Development of evaluation items for adolescents’ dietary habits and nutritional practices reflecting eating behaviors and food environment
Jimin LIM ; Hye Ji SEO ; Jieun OH
Journal of Nutrition and Health 2024;57(1):136-152
Purpose:
A comprehensive evaluation item was developed to assess adolescent dietary habits and nutritional practices, considering food intake, eating behaviors, and food culture, such as social support and food environment.
Methods:
The 59 candidate items of the evaluation checklist were obtained based on the results of the eighth Korea National Health and Nutrition Examination Survey data, Korea Dietary Reference Intakes, dietary guidelines for adolescents, Youth Risk Behavior Survey data, national nutrition policies and dietary guidelines, and literature reviews. Four hundred and three middle and high school students residing in metropolitan areas participated in a survey using the 58-item checklist, which was selected through expert evaluation and content validity ratio analysis.The construct validity of the assessment tool for the quality of adolescent diets was assessed by exploratory factor analyses to determine if the checklist items were organized properly and whether the responses to each item were distributed adequately.
Results:
The Bartlett sphericity test was significant for each area (p <0.001), and the eigen values were greater than one. The Kaiser-Meyer-Olkin and cumulative proportions by areas were food intake (0.765 and 56.8%, respectively), eating behaviors (0.544 and 64.8%, respectively), and food environment (0.699 and 62.4%, respectively). Twenty-two checklists were determined for the final evaluation items for the adolescents’ dietary habits and nutritional practices and were categorized into three distinct factors: food intake (10 items), eating behaviors (4 items), and food environment (8 items).
Conclusion
The evaluation items for adolescent dietary habits and nutritional practices is a useful checklist for easily and quickly assessing the dietary qualities and reflecting Korean adolescents and their food environmental factors related to a sustainable diet.
7.Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARSCoV-2 Monoclonal Antibody Treatment of Patients with COVID-19
Sun Bean KIM ; Jimin KIM ; Kyungmin HUH ; Won Suk CHOI ; Yae-Jean KIM ; Eun-Jeong JOO ; Youn Jeong KIM ; Young Kyung YOON ; Jung Yeon HEO ; Yu Bin SEO ; Su Jin JEONG ; Su-Yeon YU ; Kyong Ran PECK ; Miyoung CHOI ; Joon Sup YEOM ;
Infection and Chemotherapy 2021;53(2):395-403
Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In terms of this situation, there is an urgent need to investigate the clinical aspects and to develop strategies to deploy them effectively in clinical practice. Here we provide guidance for the use of anti-SARS-CoV-2 monoclonal antibodies for the treatment of COVID-19 based on the latest evidence.
8.Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19
Sun Bean KIM ; Seungeun RYOO ; Kyungmin HUH ; Eun-Jeong JOO ; Youn Jeong KIM ; Won Suk CHOI ; Yae-Jean KIM ; Young Kyung YOON ; Jung Yeon HEO ; Yu Bin SEO ; Su Jin JEONG ; Dong-ah PARK ; Su-Yeon YU ; Hyeon-Jeong LEE ; Jimin KIM ; Yan JIN ; Jungeun PARK ; Kyong Ran PECK ; Miyoung CHOI ; Joon Sup YEOM ;
Infection and Chemotherapy 2021;53(1):166-219
Despite the global effort to mitigate the spread, coronavirus disease 2019 (COVID-19) has become a pandemic that took more than 2 million lives. There are numerous ongoing clinical studies aiming to find treatment options and many are being published daily. Some effective treatment options, albeit of variable efficacy, have been discovered. Therefore, it is necessary to develop an evidence-based methodology, to continuously check for new evidence, and to update recommendations accordingly. Here we provide guidelines on pharmaceutical treatment for COVID-19 based on the latest evidence.
9.Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARSCoV-2 Monoclonal Antibody Treatment of Patients with COVID-19
Sun Bean KIM ; Jimin KIM ; Kyungmin HUH ; Won Suk CHOI ; Yae-Jean KIM ; Eun-Jeong JOO ; Youn Jeong KIM ; Young Kyung YOON ; Jung Yeon HEO ; Yu Bin SEO ; Su Jin JEONG ; Su-Yeon YU ; Kyong Ran PECK ; Miyoung CHOI ; Joon Sup YEOM ;
Infection and Chemotherapy 2021;53(2):395-403
Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In terms of this situation, there is an urgent need to investigate the clinical aspects and to develop strategies to deploy them effectively in clinical practice. Here we provide guidance for the use of anti-SARS-CoV-2 monoclonal antibodies for the treatment of COVID-19 based on the latest evidence.
10.Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19
Sun Bean KIM ; Seungeun RYOO ; Kyungmin HUH ; Eun-Jeong JOO ; Youn Jeong KIM ; Won Suk CHOI ; Yae-Jean KIM ; Young Kyung YOON ; Jung Yeon HEO ; Yu Bin SEO ; Su Jin JEONG ; Dong-ah PARK ; Su-Yeon YU ; Hyeon-Jeong LEE ; Jimin KIM ; Yan JIN ; Jungeun PARK ; Kyong Ran PECK ; Miyoung CHOI ; Joon Sup YEOM ;
Infection and Chemotherapy 2021;53(1):166-219
Despite the global effort to mitigate the spread, coronavirus disease 2019 (COVID-19) has become a pandemic that took more than 2 million lives. There are numerous ongoing clinical studies aiming to find treatment options and many are being published daily. Some effective treatment options, albeit of variable efficacy, have been discovered. Therefore, it is necessary to develop an evidence-based methodology, to continuously check for new evidence, and to update recommendations accordingly. Here we provide guidelines on pharmaceutical treatment for COVID-19 based on the latest evidence.

Result Analysis
Print
Save
E-mail